Compare $APVO vs $DCOY | Chartloom

Compare

$APVO vs $DCOY

Aptevo Therapeutics Inc · Decoy Therapeutics Inc

APVO

Aptevo Therapeutics Inc

DCOY

Decoy Therapeutics Inc

Compare $APVO vs $DCOY

Comparing Aptevo Therapeutics Inc and Decoy Therapeutics Inc

APVOAptevo Therapeutics Inc

DCOYDecoy Therapeutics Inc

APVOAptevo Therapeutics Inc

Market cap

$2M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-80.9%

52W performance

-94.2%

FCF yield

-1132.6%

DCOYDecoy Therapeutics Inc

Market cap

$779K

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-81.2%

52W performance

-97.0%

FCF yield

-1073.9%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

APVO

DCOY

Detailed metrics comparison

APVO

Aptevo Therapeutics Inc

DCOY

Decoy Therapeutics Inc

Market Cap

APVO$2M

DCOY$779K

Enterprise Value

APVO$-8M

DCOY$-8M

Price

APVO$1.79

DCOY$1.47

P/E Ratio

APVON/A

DCOYN/A

P/S Ratio

APVO0.25x

DCOY3.42x

EV/Sales

APVO-0.51x

DCOY-33.00x

EV/EBITDA

APVO-0.91x

DCOY0.00x

P/B Ratio

APVO0.53x

DCOY0.75x

P/FCF Ratio

APVON/A

DCOYN/A

EV/FCF

APVO0.30x

DCOY0.90x

PEG Ratio

APVON/A

DCOYN/A

Forward P/E (NTM)

APVON/A

DCOYN/A

Forward P/S (NTM)

APVON/A

DCOYN/A

Revenue (TTM)

APVO$0

DCOY$228K

Revenue Growth (YoY)

APVON/A

DCOYN/A

Forward Rev Growth

APVO206.8%

DCOY0.0%

Gross Margin (TTM)

APVO51.4%

DCOY48.6%

Operating Margin (TTM)

APVO0.0%

DCOY0.0%

EBITDA Margin (TTM)

APVO0.0%

DCOY-2668.9%

Net Margin (TTM)

APVO0.0%

DCOY-6348.7%

FCF Margin (TTM)

APVON/A

DCOY-3676.1%

Net Income (TTM)

APVO$-28M

DCOY$-14M

FCF (TTM)

APVO$-25M

DCOY$-8M

EPS (TTM)

APVO-$23.47

DCOY-$27.16

ROE (TTM)

APVO-20149.0%

DCOY-31523.0%

ROA (TTM)

APVO-11921.0%

DCOY-16715.0%

ROIC (TTM)

APVO-20149.0%

DCOY-31523.0%

Cash

APVO$10M

DCOY$8M

Debt

APVO$0

DCOY$0

Net Cash/Debt

APVO$10M

DCOY$8M

Current Ratio (TTM)

APVO2.08x

DCOY1.83x

Quick Ratio (TTM)

APVO1.98x

DCOY1.77x

Debt/Equity (TTM)

APVO0.00x

DCOY0.00x

Debt/Assets (TTM)

APVO0.0%

DCOY0.0%

Interest Coverage (TTM)

APVON/A

DCOYN/A

Net Debt/EBITDA (TTM)

APVO0.00x

DCOY0.00x

Beta

APVO1.68

DCOY0.68

52W Performance

APVO-94.2%

DCOY-97.0%

YTD Performance

APVO-80.9%

DCOY-81.2%

% from 52W High

APVO-94.6%

DCOY-97.4%

% from 52W Low

APVO30.7%

DCOY0.7%

Asset Turnover (TTM)

APVO0.22x

DCOY0.03x

FCF Yield (TTM)

APVO-1132.6%

DCOY-1073.9%

Earnings Yield (TTM)

APVO-1254.8%

DCOY-1854.7%

Dividend Yield (TTM)

APVON/A

DCOYN/A

Rule of 40

APVO0.0

DCOY-3,676.1

EV/GP/RG

APVON/A

DCOYN/A

Ticker research

View APVO research View DCOY research

Metric	APVO Aptevo Therapeutics Inc	DCOY Decoy Therapeutics Inc
Market & Valuation
Market Cap	$2M	$779K
Enterprise Value	$-8M	$-8M
Price	$1.79	$1.47
P/E Ratio	N/A	N/A
P/S Ratio	0.25x	3.42x
EV/Sales	-0.51x	-33.00x
EV/EBITDA	-0.91x	0.00x
P/B Ratio	0.53x	0.75x
P/FCF Ratio	N/A	N/A
EV/FCF	0.30x	0.90x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$228K
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	206.8%	0.0%
Profitability
Gross Margin (TTM)	51.4%	48.6%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-2668.9%
Net Margin (TTM)	0.0%	-6348.7%
FCF Margin (TTM)	N/A	-3676.1%
Net Income (TTM)	$-28M	$-14M
FCF (TTM)	$-25M	$-8M
EPS (TTM)	-$23.47	-$27.16
ROE (TTM)	-20149.0%	-31523.0%
ROA (TTM)	-11921.0%	-16715.0%
ROIC (TTM)	-20149.0%	-31523.0%
Financial Health
Cash	$10M	$8M
Debt	$0	$0
Net Cash/Debt	$10M	$8M
Current Ratio (TTM)	2.08x	1.83x
Quick Ratio (TTM)	1.98x	1.77x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.68	0.68
52W Performance	-94.2%	-97.0%
YTD Performance	-80.9%	-81.2%
% from 52W High	-94.6%	-97.4%
% from 52W Low	30.7%	0.7%
Efficiency & Yields
Asset Turnover (TTM)	0.22x	0.03x
FCF Yield (TTM)	-1132.6%	-1073.9%
Earnings Yield (TTM)	-1254.8%	-1854.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-3,676.1
EV/GP/RG	N/A	N/A
Ticker research	View APVO research	View DCOY research

Valuation

P/S Ratio

APVO

0.25x

DCOY

3.42x

EV/FCF

APVO

0.30x

DCOY

0.90x

Growth & revenue

Forward Revenue Growth

APVO

206.8%

DCOY

0.0%

Profitability & performance

Gross Margin

APVO

51.4%

DCOY

48.6%

ROE

APVO

-20149.0%

DCOY

-31523.0%

FCF Yield %

DCOY

-1073.9%

APVO

-1132.6%

52-Week Performance

APVO

-94.2%

DCOY

-97.0%

Detailed metrics comparison

APVO

Aptevo Therapeutics Inc

DCOY

Decoy Therapeutics Inc

Market Cap

APVO$2M

DCOY$779K

Enterprise Value

APVO$-8M

DCOY$-8M

Price

APVO$1.79

DCOY$1.47

P/E Ratio

APVON/A

DCOYN/A

P/S Ratio

APVO0.25x

DCOY3.42x

EV/Sales

APVO-0.51x

DCOY-33.00x

EV/EBITDA

APVO-0.91x

DCOY0.00x

P/B Ratio

APVO0.53x

DCOY0.75x

P/FCF Ratio

APVON/A

DCOYN/A

EV/FCF

APVO0.30x

DCOY0.90x

PEG Ratio

APVON/A

DCOYN/A

Forward P/E (NTM)

APVON/A

DCOYN/A

Forward P/S (NTM)

APVON/A

DCOYN/A

Revenue (TTM)

APVO$0

DCOY$228K

Revenue Growth (YoY)

APVON/A

DCOYN/A

Forward Rev Growth

APVO206.8%

DCOY0.0%

Gross Margin (TTM)

APVO51.4%

DCOY48.6%

Operating Margin (TTM)

APVO0.0%

DCOY0.0%

EBITDA Margin (TTM)

APVO0.0%

DCOY-2668.9%

Net Margin (TTM)

APVO0.0%

DCOY-6348.7%

FCF Margin (TTM)

APVON/A

DCOY-3676.1%

Net Income (TTM)

APVO$-28M

DCOY$-14M

FCF (TTM)

APVO$-25M

DCOY$-8M

EPS (TTM)

APVO-$23.47

DCOY-$27.16

ROE (TTM)

APVO-20149.0%

DCOY-31523.0%

ROA (TTM)

APVO-11921.0%

DCOY-16715.0%

ROIC (TTM)

APVO-20149.0%

DCOY-31523.0%

Cash

APVO$10M

DCOY$8M

Debt

APVO$0

DCOY$0

Net Cash/Debt

APVO$10M

DCOY$8M

Current Ratio (TTM)

APVO2.08x

DCOY1.83x

Quick Ratio (TTM)

APVO1.98x

DCOY1.77x

Debt/Equity (TTM)

APVO0.00x

DCOY0.00x

Debt/Assets (TTM)

APVO0.0%

DCOY0.0%

Interest Coverage (TTM)

APVON/A

DCOYN/A

Net Debt/EBITDA (TTM)

APVO0.00x

DCOY0.00x

Beta

APVO1.68

DCOY0.68

52W Performance

APVO-94.2%

DCOY-97.0%

YTD Performance

APVO-80.9%

DCOY-81.2%

% from 52W High

APVO-94.6%

DCOY-97.4%

% from 52W Low

APVO30.7%

DCOY0.7%

Asset Turnover (TTM)

APVO0.22x

DCOY0.03x

FCF Yield (TTM)

APVO-1132.6%

DCOY-1073.9%

Earnings Yield (TTM)

APVO-1254.8%

DCOY-1854.7%

Dividend Yield (TTM)

APVON/A

DCOYN/A

Rule of 40

APVO0.0

DCOY-3,676.1

EV/GP/RG

APVON/A

DCOYN/A

Ticker research

View APVO research View DCOY research

Metric	APVO Aptevo Therapeutics Inc	DCOY Decoy Therapeutics Inc
Market & Valuation
Market Cap	$2M	$779K
Enterprise Value	$-8M	$-8M
Price	$1.79	$1.47
P/E Ratio	N/A	N/A
P/S Ratio	0.25x	3.42x
EV/Sales	-0.51x	-33.00x
EV/EBITDA	-0.91x	0.00x
P/B Ratio	0.53x	0.75x
P/FCF Ratio	N/A	N/A
EV/FCF	0.30x	0.90x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$228K
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	206.8%	0.0%
Profitability
Gross Margin (TTM)	51.4%	48.6%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-2668.9%
Net Margin (TTM)	0.0%	-6348.7%
FCF Margin (TTM)	N/A	-3676.1%
Net Income (TTM)	$-28M	$-14M
FCF (TTM)	$-25M	$-8M
EPS (TTM)	-$23.47	-$27.16
ROE (TTM)	-20149.0%	-31523.0%
ROA (TTM)	-11921.0%	-16715.0%
ROIC (TTM)	-20149.0%	-31523.0%
Financial Health
Cash	$10M	$8M
Debt	$0	$0
Net Cash/Debt	$10M	$8M
Current Ratio (TTM)	2.08x	1.83x
Quick Ratio (TTM)	1.98x	1.77x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.68	0.68
52W Performance	-94.2%	-97.0%
YTD Performance	-80.9%	-81.2%
% from 52W High	-94.6%	-97.4%
% from 52W Low	30.7%	0.7%
Efficiency & Yields
Asset Turnover (TTM)	0.22x	0.03x
FCF Yield (TTM)	-1132.6%	-1073.9%
Earnings Yield (TTM)	-1254.8%	-1854.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-3,676.1
EV/GP/RG	N/A	N/A
Ticker research	View APVO research	View DCOY research